相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome
Simona Lattanzi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)
Equivalence of regression curves sharing common parameters
Kathrin Moellenhoff et al.
BIOMETRICS (2020)
dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice
Gaia Colasante et al.
MOLECULAR THERAPY (2020)
Antiepileptic Drug Ethosuximide May Regulate Absence Seizures Through Different Ion Channels
Boris Shalomov et al.
BIOPHYSICAL JOURNAL (2020)
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
CNS DRUGS (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Dravet Syndrome: A Review of Current Management
James W. Wheless et al.
PEDIATRIC NEUROLOGY (2020)
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens A Randomized Clinical Trial
Rima Nabbout et al.
JAMA NEUROLOGY (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis
Simona Lattanzi et al.
EPILEPSIA (2020)
Placebo by Proxy and Nocebo by Proxy in Children: A Review of Parents' Role in Treatment Outcomes
Efrat Czerniak et al.
FRONTIERS IN PSYCHIATRY (2020)
Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials
Orrin Devinsky et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
Gianluca D'Onofrio et al.
FRONTIERS IN NEUROLOGY (2020)
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
Philip N. Patsalos et al.
EPILEPSIA (2020)
Impact of predictive, preventive and precision medicine strategies in epilepsy
Rima Nabbout et al.
NATURE REVIEWS NEUROLOGY (2020)
Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis
Yan-Qiu Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent
Royston A. Gray et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures
Rima Nabbout et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)
Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
Angela K. Birnbaum et al.
EPILEPSIA (2019)
Tablet Scoring: Current Practice, Fundamentals, and Knowledge Gaps
Emmanuel Reginald Jacques et al.
APPLIED SCIENCES-BASEL (2019)
Stiripentol: A Review in Dravet Syndrome
James E. Frampton
DRUGS (2019)
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson et al.
EPILEPSIA (2019)
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Michele Romoli et al.
CURRENT NEUROPHARMACOLOGY (2019)
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Orrin Devinsky et al.
EPILEPSIA (2019)
Behavior problems and health-related quality of life in Dravet syndrome
Claudia Sinoo et al.
EPILEPSY & BEHAVIOR (2019)
A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
Brooks Boyd et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2019)
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
Lieven Lagae et al.
LANCET (2019)
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
Gilmour Morrison et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
The clinical outcome and neuroimaging of acute encephalopathy after status epilepticus in Dravet syndrome
Xiaojuan Tian et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes
Iris M. de Lange et al.
EPILEPSIA (2018)
Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome
Rima Nabbout et al.
EPILEPSY & BEHAVIOR (2018)
Off-label use and manipulations of antiepileptic drugs in children: Analysis of the outpatient prescriptions in a tertiary center
Mathieu Kuchenbuch et al.
EPILEPSY & BEHAVIOR (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents
Giulia Iapadre et al.
PEDIATRIC DRUGS (2018)
Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy
Sophie Peigne et al.
CLINICAL PHARMACOKINETICS (2018)
Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
Catherine Chiron et al.
EPILEPSIA (2018)
Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey
Lieven Lagae et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Audit of use of stiripentol in adults with Dravet syndrome
S. Balestrini et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Dravet syndrome and its mimics: Beyond SCN1A
Dora Steel et al.
EPILEPSIA (2017)
Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol
Evan C. Rosenberg et al.
EPILEPSIA (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
Age-related Sleep/nocturnal tonic and tonic clonic seizure clusters are underdiagnosed in patients with Dravet Syndrome
Emma Losito et al.
EPILEPSY & BEHAVIOR (2017)
Dravet syndrome: Characteristics, comorbidities, and caregiver concerns
Nicole Villas et al.
EPILEPSY & BEHAVIOR (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen
Viviana Giannuzzi et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Parental Perception of Comorbidities in Children With Dravet Syndrome
Kelly G. Knupp et al.
PEDIATRIC NEUROLOGY (2017)
Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients
Maxine Dibue-Adjei et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Effect of CYP Inducers/Inhibitors on Topiramate Concentration: Clinical Value of Therapeutic Drug Monitoring
Yoshiaki Yamamoto et al.
THERAPEUTIC DRUG MONITORING (2017)
Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Jo Sourbron et al.
FRONTIERS IN PHARMACOLOGY (2017)
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions
Jean-Marie Nicolas et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2017)
Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine
Berten Ceulemans et al.
EPILEPSIA (2016)
Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study
Paola De Liso et al.
EPILEPSY RESEARCH (2016)
Mortality in Dravet syndrome
Monica S. Cooper et al.
EPILEPSY RESEARCH (2016)
Safety of Levetiracetam in Paediatrics: A Systematic Review
Oluwaseun Egunsola et al.
PLOS ONE (2016)
Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome
J. Hsiao et al.
EBIOMEDICINE (2016)
Effect of CYP2C19 polymorphisnis on stiripentol administration in Japanese cases of Dravet syndrome
Takeshi Kouga et al.
BRAIN & DEVELOPMENT (2015)
The incidence of SCN1A-related Dravet syndrome in Denmark is 1: 22,000: A population-based study from 2004 to 2009
Allan Bayat et al.
EPILEPSIA (2015)
Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen
Anastasia Dressler et al.
EPILEPSY RESEARCH (2015)
Targeting LDH enzymes with a stiripentol analog to treat epilepsy
Nagisa Sada et al.
SCIENCE (2015)
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy
Valentina Franco et al.
CNS DRUGS (2014)
Absence Epilepsy: Older vs Newer AEDs
Jeffrey R. Tenney et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Zonisamide: Pharmacokinetics, Efficacy, and Adverse Events in Children with Epilepsy
Karin M. Wallander et al.
NEUROPEDIATRICS (2014)
Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for α2- versus α1-GABAA-Receptor Complexes
Henrik Sindal Jensen et al.
PLOS ONE (2014)
Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome
Chao Tai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy
Junji Saruwatari et al.
THERAPEUTIC DRUG MONITORING (2014)
Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital
Jennifer R. Bellis et al.
BMC MEDICINE (2013)
Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age: An Update
Domenico Italiano et al.
CLINICAL PHARMACOKINETICS (2013)
A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy
Renzo Guerrini et al.
EPILEPSIA (2013)
Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain
Stephane Auvin et al.
EPILEPSIA (2013)
Stiripentol in Dravet syndrome: Results of a retrospective US study
Elaine C. Wirrell et al.
EPILEPSIA (2013)
Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
Rima Nabbout et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Influence of CYP2C19 Polymorphism and Concomitant Antiepileptic Drugs on Serum Clobazam and N-Desmethyl Clobazam Concentrations in Patients With Epilepsy
Yoshiaki Yamamoto et al.
THERAPEUTIC DRUG MONITORING (2013)
Progressive Gait Deterioration in Adolescents With Dravet Syndrome
Jill M. Rodda et al.
ARCHIVES OF NEUROLOGY (2012)
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
A. Brunklaus et al.
BRAIN (2012)
Successful use of fenfluramine as an add-on treatment for Dravet syndrome
Berten Ceulemans et al.
EPILEPSIA (2012)
Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis
Xiaoyuan Mao et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome
Jan Lotte et al.
NEUROPEDIATRICS (2012)
Pharmacokinetic Variability of Four Newer Antiepileptic Drugs, Lamotrigine, Levetiracetam, Oxcarbazepine, and Topiramate: A Comparison of the Impact of Age and Comedication
Cecilie Johannessen Landmark et al.
THERAPEUTIC DRUG MONITORING (2012)
Overall management of patients with Dravet syndrome
Berten Ceulemans
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
The pharmacologic treatment of Dravet syndrome
Catherine Chiron et al.
EPILEPSIA (2011)
Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief
Joan V. Skluzacek et al.
EPILEPSIA (2011)
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
A. Mueller et al.
EPILEPSY & BEHAVIOR (2011)
Interactions between modulators of the GABAA receptor: Stiripentol and benzodiazepines
Janet L. Fisher
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: Continuous spikes and waves during sleep is definitely a target
S. Chhun et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Drug interactions involving the new second- and third-generation antiepileptic drugs
Cecilie Johannessen Landmark et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Unusual consequences of status epilepticus in Dravet syndrome
M. Chipaux et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
Stiripentol open study in Japanese patients with Dravet syndrome
Yushi Inoue et al.
EPILEPSIA (2009)
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy
P. Striano et al.
NEUROLOGY (2007)
Topiramate in the treatment of highly refractory patients with Dravet syndrome
J. Kroll-Seger et al.
NEUROPEDIATRICS (2006)
Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis
Jarogniew J. Luszczki et al.
EPILEPSIA (2006)
Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe+++-induced epileptic rats
T Doi et al.
MOLECULAR BRAIN RESEARCH (2005)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Topiramate slow dose titration: improved efficacy and tolerability
AM Albsoul-Younes et al.
PEDIATRIC NEUROLOGY (2004)
Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures
Y Ueda et al.
MOLECULAR BRAIN RESEARCH (2003)
The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents
JM Rigo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial
G Coppola et al.
EPILEPSY RESEARCH (2002)
Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy
Y Saito et al.
NEUROPEDIATRICS (2001)
Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study
P Uldall et al.
EPILEPSY RESEARCH (2000)
Topiramate in the treatment of severe myoclonic epilepsy in infancy
M Nieto-Barrera et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
C Chiron et al.
LANCET (2000)
分享论文
